Anna Bar Selected Research

S961 peptide

1/2021

Systemic Administration of Insulin Receptor Antagonist Results in Endothelial and Perivascular Adipose Tissue Dysfunction in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Bar Research Topics

Disease

9	Melanoma (Melanoma, Malignant) 12/2023 - 01/2020
3	Heart Failure 12/2023 - 01/2018
3	Inflammation (Inflammations) 10/2023 - 01/2019
3	Neoplasms (Cancer) 01/2023 - 06/2012
3	Atherosclerosis 11/2019 - 01/2016
2	Insulin Resistance 01/2021 - 11/2020
2	Atherosclerotic Plaque (Atheroma) 11/2019 - 01/2019
1	Thrombosis (Thrombus) 02/2024
1	Hemorrhage 12/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2023
1	Myocarditis (Carditis) 10/2023
1	Necrosis 10/2023
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Skin Neoplasms (Skin Cancer) 10/2021
1	Hypertension (High Blood Pressure) 08/2021
1	Hyperglycemia 01/2021
1	Obesity 01/2021
1	Disease Progression 01/2020
1	Endotoxemia 01/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016
1	Margins of Excision 06/2012

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2019
3	Apolipoproteins E (ApoE)IBA 11/2019 - 01/2016
2	AntibodiesIBA 10/2023 - 09/2023
2	AntigensIBA 09/2023 - 10/2021
2	Thrombin FDA Link 08/2021 - 11/2019
2	Angiopoietin-2IBA 11/2020 - 01/2019
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2020 - 01/2019
2	Plasminogen Activator Inhibitor 1IBA 11/2020 - 01/2019
2	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2020 - 01/2019
2	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2019 - 01/2019
2	AngiotensinsIBA 01/2018 - 01/2017
1	Protein Disulfide-IsomerasesIBA 02/2024
1	Chymases (Chymase)IBA 12/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2023
1	Peptides (Polypeptides)IBA 10/2023
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 10/2023
1	CytokinesIBA 10/2023
1	Microphthalmia-Associated Transcription FactorIBA 09/2023
1	MART-1 AntigenIBA 01/2023
1	Hypoxia-Inducible Factor 1IBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	AmidesIBA 01/2022
1	Fibronectins (Fibronectin)IBA 01/2022
1	VaccinesIBA 10/2021
1	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 08/2021
1	Angiotensin IIIBA 08/2021
1	Dabigatran FDA Link 08/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Insulin ReceptorIBA 01/2021
1	S961 peptideIBA 01/2021
1	NitritesIBA 11/2020
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2020
1	E-SelectinIBA 11/2020
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 11/2020
1	Syndecan-1 (Syndecan 1)IBA 11/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	NitratesIBA 11/2019
1	LDL Receptors (LDL Receptor)IBA 01/2019
1	ApolipoproteinsIBA 01/2019
1	LectinsIBA 01/2018
1	Sodium Channels (Sodium Channel)IBA 01/2018
1	Perindopril FDA LinkGeneric 01/2017
1	EnzymesIBA 01/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2017
1	oil red OIBA 01/2016
1	Hematoxylin (Haematoxylon)IBA 06/2012
1	Eosine Yellowish-(YS) (Eosin)IBA 06/2012

Therapy/Procedure

10	Mohs Surgery (Mohs' Micrographic Surgery) 12/2023 - 01/2020
5	Therapeutics 10/2023 - 01/2020
1	Subcutaneous Injections 12/2023
1	Immunotherapy 10/2021